GRAIL, Inc. (NASDAQ:GRAL) Given Average Recommendation of "Hold" by Brokerages

Shares of GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) have been given a consensus recommendation of "Hold" by the ten research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $67.7778.

A number of equities research analysts have issued reports on GRAL shares. Wolfe Research assumed coverage on shares of GRAIL in a research note on Tuesday, June 2nd. They set a "peer perform" rating on the stock. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of GRAIL in a report on Friday, July 17th. The Goldman Sachs Group began coverage on shares of GRAIL in a report on Friday, June 5th. They set a "neutral" rating and a $60.00 price target for the company. TD Cowen reissued a "buy" rating on shares of GRAIL in a research note on Wednesday, July 15th. Finally, Mizuho boosted their price objective on shares of GRAIL from $58.00 to $65.00 and gave the company a "neutral" rating in a research report on Wednesday, July 15th.

GRAIL Stock Performance

NASDAQ:GRAL opened at $80.34 on Monday. The stock has a fifty day moving average price of $72.54 and a 200-day moving average price of $62.72. The company has a market cap of $3.59 billion, a price-to-earnings ratio of -8.24 and a beta of 3.25. GRAIL has a fifty-two week low of $33.61 and a fifty-two week high of $118.84.

GRAIL (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported ($2.56) EPS for the quarter, topping analysts' consensus estimates of ($2.66) by $0.10. The company had revenue of $44.69 million for the quarter, compared to analysts' expectations of $42.39 million. GRAIL had a negative return on equity of 15.88% and a negative net margin of 236.95%. Research analysts predict that GRAIL will post -10.41 EPS for the current fiscal year.

Insider Activity

In other GRAIL news, CEO Joshua Ofman sold 5,000 shares of the business's stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $85.02, for a total transaction of $425,100.00. Following the completion of the transaction, the chief executive officer owned 397,271 shares of the company's stock, valued at approximately $33,775,980.42. The trade was a 1.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Aaron Freidin sold 7,900 shares of the stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $85.01, for a total transaction of $671,579.00. Following the completion of the transaction, the chief financial officer directly owned 253,083 shares of the company's stock, valued at $21,514,585.83. This trade represents a 3.03% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.83% of the company's stock.

Institutional Trading of GRAIL

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of America Corp DE raised its position in GRAIL by 29.0% during the 1st quarter. Bank of America Corp DE now owns 914,114 shares of the company's stock worth $47,241,000 after purchasing an additional 205,611 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in GRAIL by 255.6% during the 2nd quarter. Russell Investments Group Ltd. now owns 28,403 shares of the company's stock worth $1,939,000 after acquiring an additional 20,416 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in shares of GRAIL by 154,361.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 91,132 shares of the company's stock valued at $7,531,000 after purchasing an additional 91,073 shares during the period. Vanguard Group Inc. lifted its stake in GRAIL by 9.0% in the fourth quarter. Vanguard Group Inc. now owns 1,980,783 shares of the company's stock valued at $169,535,000 after buying an additional 163,790 shares during the period. Finally, WIM INVESTMENT MANAGEMENT Ltd increased its stake in shares of GRAIL by 68.9% in the 4th quarter. WIM INVESTMENT MANAGEMENT Ltd now owns 106,400 shares of the company's stock valued at $9,107,000 after acquiring an additional 43,400 shares in the last quarter.

GRAIL Company Profile

GRAIL, Inc NASDAQ: GRAL is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company's platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source